Quantitative EEG Neurofeedback for the Treatment of Pediatric Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorders, Learning Disorders, and Epilepsy - 28/06/14
, L. Eugene Arnold, MD, MEd b, Nicholas Lofthouse, PhD cRésumé |
Neurofeedback (NF) using surface electroencephalographic signals has been used to treat various child psychiatric disorders by providing patients with video/audio information about their brain’s electrical activity in real-time. Research data are reviewed and clinical recommendations are made regarding NF treatment of youth with attention deficit/hyperactivity disorder, autism, learning disorders, and epilepsy. Most NF studies are limited by methodological issues, such as failure to use or test the validity of a full-blind or sham NF. The safety of NF treatment has not been thoroughly investigated in youth or adults, although clinical experience suggests reasonable safety.
Le texte complet de cet article est disponible en PDF.Keywords : Neurofeedback, Neurotherapy, EEG biofeedback, Quantitative EEG, ADHD, Autism spectrum disorders, Learning disorders, Epilepsy
Plan
| Disclosures: Dr L.E. Arnold has had research funding from CureMark, Lilly, and Shire, been on advisory boards for AstraZeneca, Biomarin, Novartis, Noven, Seaside Therapeutics, and Shire, and had travel support from Noven. Dr E. Hurt has had research funding from Bristol-Meyer-Squibb. Dr N. Lofthouse has no financial disclosures. |
Vol 23 - N° 3
P. 465-486 - juillet 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
